Technology

Envisioning Medical Technology and the Future of Healthcare

2 Mins read

In reviewing the interesting graphic from Envisioning Technology, I find this overview of technology interesting for its attempt to capture a wide range of technologies and represent them visually, grouping current and future technologies into these six categories:

In reviewing the interesting graphic from Envisioning Technology, I find this overview of technology interesting for its attempt to capture a wide range of technologies and represent them visually, grouping current and future technologies into these six categories:

  • Augmentation
  • Regeneration
  • Diagnostics
  • Telemedicine
  • Biogerontology
  • Treatments

While the graphic’s details encompass a good range of important technologies that will sooner or later impact healthcare, the graphic has several key problems. First, there are a few errant placements (too early or too late) of technology. This of course may simply ensue from subjectivity, which one of the principals behind the graphic, Michell Zappa, acknowledges (“actual forecast of when certain technologies are likely to reach maturity [or the] mainstream is very subjective”).

Second, the segmentation of technologies by the six categories above artificially separates groupings of technologies that naturally belong together. For example, biogerontology is wholly and intrinsically linked with regeneration. Treatments and regeneration are too close to be considered distinct.  Telemedicine and diagnostics are initially one and the same, with emerging technologies expanding on the therapeutic aspect of telemedicine (e.g., remote surgery, remote inteventional medicine, and other telepresence capabilities).

Of course, all systems of categorization are at their root a simplified representation of a complex system for the purpose of identifying discrete sets of elements with common characteristics.  Also, the old adage is true that, “All forecasts are wrong; some forecasts are more wrong than others”.

What I fundamentally appreciate about this type of visualization is its attempt to reflect in some form — especially in capturing a macro view that understands both trees and forests — the relatedness, interconnectivity and otherwise dynamic interactions between elements that are otherwise seen disparately. The macro view captures chronology, sequential progression, functional associations and similar.

Therefore, the only limitations I see to these representations are the conceptual macro ideas that are intended to be represented and this is not stated or obvious in the Envisioning Technology graphic.  In other words, what understanding is being portrayed by segmenting technology by the categories of Augmentation, Regeneration, etc.?  Moreover, the implicit assumption that “now” is at the center of the graphic misses a fundamental tenet of medical technology development.

Let me elaborate.  Like a family tree, a representation of Now at the center reflects a view that, as we expanding radially outward, we are encountering an ever-widening circle in which there is continued proliferation and differentiation of elements (children, grandchildren, etc.).  However, one of the fundamental aspects of current and emerging medical technology development that makes it so stunning is the convergence of technology as medical science gains the ability to both comprehend systems more as a whole than disparate parts (cardiology, orthopedics, neurology, etc.) and intervene more comprehensively with therapeutic solutions that, minimally, do not produce collateral damage on adjacent systems and, optimally, leverage the body’s comprehensive physiology in recovering from disease and trauma.

Therefore, a more cogent argument can be made that, for a variety of reasons, including the convergence of multiple scientific disciplines, the financial limitations of healthcare expenditure and others, the center of the graphic ought to perhaps be the future, with trends and developments being driven toward a smaller number of more comprehensive healthcare solutions.

 

     me

Avatar
183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Articles
Related posts
eHealthTechnology

Eco-Friendly Practice: How Hospitals Can Adapt To Protect The Planet

3 Mins read
Hospitals around the world are busier than ever before. Every health care facility requires a significant amount of energy to operate effectively….
Medical InnovationsSpecialtiesTechnology

Deciphering the Controversy of Adipose Derived Stem Cells in the Context of Healthcare

4 Mins read
As we enter a new era of medical advancements, several new techniques in medicine have been pioneered. You may have heard of…
Medical InnovationsTechnology

5 AI Hotspots In Medicine To Know About

3 Mins read
Medicine moves slowly — until it doesn’t. Sometimes, a technology like CRISPR comes along that changes the treatment landscape for dozens of…